ORLANDO, FL — In the AVERT trial of close to 600 patients who underwent coronary angiography and were at high risk of contrast-induced acute kidney injury (AKI), the studied device successfully ...
Please provide your email address to receive an email when new articles are posted on . A speaker highlighted key advances in thrombosis and coronary disease treatment in 2024. Topics included updated ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results